|
FAM161A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.583610E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.258170E-01 |
| Normal-vs-Stage2 |
8.713200E-01 |
| Normal-vs-Stage3 |
4.70399999996651E-06 |
| Normal-vs-Stage4 |
4.84710000026034E-07 |
| Stage1-vs-Stage2 |
4.953600E-01 |
| Stage1-vs-Stage3 |
2.063100E-03 |
| Stage1-vs-Stage4 |
2.015000E-04 |
| Stage2-vs-Stage3 |
5.999800E-02 |
| Stage2-vs-Stage4 |
4.023600E-02 |
| Stage3-vs-Stage4 |
6.804800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.721500E-03 |
| Normal-vs-AfricanAmerican |
7.91620000000215E-05 |
| Normal-vs-Asian |
7.030400E-01 |
| Caucasian-vs-AfricanAmerican |
2.296200E-02 |
| Caucasian-vs-Asian |
3.792400E-01 |
| AfricanAmerican-vs-Asian |
3.834000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.010290E-02 |
| Normal-vs-Female |
1.978500E-03 |
| Male-vs-Female |
4.661800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.577400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.360630E-01 |
| Normal-vs-Age(61-80Yrs) |
3.590400E-04 |
| Normal-vs-Age(81-100Yrs) |
6.796500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.319800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.650000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.951600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.198370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.066400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.179200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.557600E-01 |
| Normal-vs-Grade 2 |
3.656800E-01 |
| Normal-vs-Grade 3 |
4.4420000000045E-05 |
| Normal-vs-Grade 4 |
2.63819999180015E-09 |
| Grade 1-vs-Grade 2 |
2.916600E-01 |
| Grade 1-vs-Grade 3 |
1.385910E-02 |
| Grade 1-vs-Grade 4 |
1.593440E-04 |
| Grade 2-vs-Grade 3 |
3.295600E-03 |
| Grade 2-vs-Grade 4 |
2.32610000039379E-07 |
| Grade 3-vs-Grade 4 |
3.895100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.241000E-01 |
| Normal-vs-ccB subtype |
1.976610E-04 |
| ccA subtype-vs-ccB subtype |
2.39779999999801E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.662300E-02 |
| Normal-vs-N1 |
1.53723999999356E-05 |
| N0-vs-N1 |
1.368160E-02 |
|
|
